-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] With the normalization of centralized procurement, pharmaceutical companies are facing more intense competition
.
Consistency evaluation is the premise for the qualification of generic drugs to participate in centralized drug procurement
.
In this context, many pharmaceutical companies are increasing investment in research and development, improving the quality of research and development, and speeding up the evaluation
.
Recently, the "Cefoxitin Sodium for Injection (1.
0g/2.
0g)" of North China Pharmaceutical Hebei Huamin Pharmaceutical Co.
, Ltd.
passed the consistency evaluation of the quality and efficacy of generic drugs
.
Cefoxitin sodium for injection is an anti-infective drug, suitable for upper and lower respiratory tract infections, bone and joint soft tissue infections, endocarditis infections and other infections caused by pathogens sensitive to the drug
.
According to data from Minet.
com, the peak sales of this product in public medical institutions in China once exceeded 5.
5 billion yuan, and it has declined in recent years, but in 2020, the sales volume will still exceed 2.
5 billion yuan
.
Up to now, there are Yangtze River, Shandong Luoxin Pharmaceutical, Xinlitai, etc.
that have been evaluated for this variety
.
Yuekang Pharmaceutical announced on the evening of March 23 that the company's lansoprazole for injection passed the consistency evaluation of the quality and efficacy of generic drugs
.
Lansoprazole for injection is suitable for gastric, duodenal ulcers, acute stress ulcers, and acute gastric mucosal injury with bleeding that are not suitable for oral therapy
.
According to IQVIA data, the global sales of lansoprazole for injection in 2020 is US$210 million (calculated at the ex-factory price), and the sales value in China is 1.
77 billion yuan (calculated at the tender price)
.
On March 22, Chongqing Huasen Pharmaceutical announced that the "Terazosin Hydrochloride Capsules (trade name: Oldman) declared by the company passed the quality and efficacy consistency evaluation of generic drugs
.
At the same time, it agreed to change the quality standards of the drug's prescription process.
.
Terazosin hydrochloride capsules are mainly used for the treatment of benign prostatic hyperplasia, but also for the treatment of hypertension
.
The drug has been included in the National Essential Drugs List (2018 Edition) and the National Medical Insurance Drug List (2004-2021 Edition)
.
Up to now, there are 3 domestic terazosin hydrochloride capsule companies that have passed or are deemed to have passed the consistency evaluation
.
Tianyao announced on the evening of March 22 that the dexamethasone sodium phosphate injection of its subsidiary Jinyao Pharmaceutical passed the quality and efficacy consistency evaluation of generic drugs
.
Dexamethasone Sodium Phosphate Injection is mainly used for allergic and autoimmune inflammatory diseases, and also for the comprehensive treatment of some serious infections, poisoning and malignant lymphoma
.
According to the data of Minet.
com, the sales of dexamethasone sodium phosphate injection in 2020 are about 229 million yuan, and the sales in the first half of 2021 are about 135 million yuan
.
So far, including Jinyao Pharmaceutical, only three companies have passed the consistency evaluation
.
According to the industry, passing the consistency evaluation of generic drugs means that the product has the same quality and efficacy as the original drug, and has been recognized by the Food and Drug Administration.
Expand the market share of the company's products and enhance market competitiveness
.
At the same time, it has accumulated rich experience for the enterprise's follow-up consistency evaluation product research, and further improved the overall R&D level and R&D ability of the enterprise
.
According to relevant policies, the over-rated varieties will receive greater support in the fields of medical insurance payment and medical institution procurement
.
For patients, drugs that have passed the consistency evaluation also greatly reduce the drug burden of patients while ensuring that the quality and efficacy of the drugs are consistent with the original drugs
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
Consistency evaluation is the premise for the qualification of generic drugs to participate in centralized drug procurement
.
In this context, many pharmaceutical companies are increasing investment in research and development, improving the quality of research and development, and speeding up the evaluation
.
Recently, the "Cefoxitin Sodium for Injection (1.
0g/2.
0g)" of North China Pharmaceutical Hebei Huamin Pharmaceutical Co.
, Ltd.
passed the consistency evaluation of the quality and efficacy of generic drugs
.
Cefoxitin sodium for injection is an anti-infective drug, suitable for upper and lower respiratory tract infections, bone and joint soft tissue infections, endocarditis infections and other infections caused by pathogens sensitive to the drug
.
According to data from Minet.
com, the peak sales of this product in public medical institutions in China once exceeded 5.
5 billion yuan, and it has declined in recent years, but in 2020, the sales volume will still exceed 2.
5 billion yuan
.
Up to now, there are Yangtze River, Shandong Luoxin Pharmaceutical, Xinlitai, etc.
that have been evaluated for this variety
.
Yuekang Pharmaceutical announced on the evening of March 23 that the company's lansoprazole for injection passed the consistency evaluation of the quality and efficacy of generic drugs
.
Lansoprazole for injection is suitable for gastric, duodenal ulcers, acute stress ulcers, and acute gastric mucosal injury with bleeding that are not suitable for oral therapy
.
According to IQVIA data, the global sales of lansoprazole for injection in 2020 is US$210 million (calculated at the ex-factory price), and the sales value in China is 1.
77 billion yuan (calculated at the tender price)
.
On March 22, Chongqing Huasen Pharmaceutical announced that the "Terazosin Hydrochloride Capsules (trade name: Oldman) declared by the company passed the quality and efficacy consistency evaluation of generic drugs
.
At the same time, it agreed to change the quality standards of the drug's prescription process.
.
Terazosin hydrochloride capsules are mainly used for the treatment of benign prostatic hyperplasia, but also for the treatment of hypertension
.
The drug has been included in the National Essential Drugs List (2018 Edition) and the National Medical Insurance Drug List (2004-2021 Edition)
.
Up to now, there are 3 domestic terazosin hydrochloride capsule companies that have passed or are deemed to have passed the consistency evaluation
.
Tianyao announced on the evening of March 22 that the dexamethasone sodium phosphate injection of its subsidiary Jinyao Pharmaceutical passed the quality and efficacy consistency evaluation of generic drugs
.
Dexamethasone Sodium Phosphate Injection is mainly used for allergic and autoimmune inflammatory diseases, and also for the comprehensive treatment of some serious infections, poisoning and malignant lymphoma
.
According to the data of Minet.
com, the sales of dexamethasone sodium phosphate injection in 2020 are about 229 million yuan, and the sales in the first half of 2021 are about 135 million yuan
.
So far, including Jinyao Pharmaceutical, only three companies have passed the consistency evaluation
.
According to the industry, passing the consistency evaluation of generic drugs means that the product has the same quality and efficacy as the original drug, and has been recognized by the Food and Drug Administration.
Expand the market share of the company's products and enhance market competitiveness
.
At the same time, it has accumulated rich experience for the enterprise's follow-up consistency evaluation product research, and further improved the overall R&D level and R&D ability of the enterprise
.
According to relevant policies, the over-rated varieties will receive greater support in the fields of medical insurance payment and medical institution procurement
.
For patients, drugs that have passed the consistency evaluation also greatly reduce the drug burden of patients while ensuring that the quality and efficacy of the drugs are consistent with the original drugs
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
